Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North o...(le arcs of the treatment machine around ...),Health

Date:10/30/2009

le arcs of the treatment machine around the patient and makes it possible to deliver image-guided intensity modulated radiotherapy (IMRT) two to eight times faster than is possible with conventional IMRT. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery and, with less time on the treatment couch, also allow for greater patient comfort.

Novalis Tx from Varian and BrainLAB features very high dose delivery rates, which contributes to shorter treatment times. It also offers dynamic fine beam shaping using the HD-120 high definition multi-leaf collimator (MLC) and non-invasive, precise patient positioning. The integrated On-Board Imager® device pinpoints the target and enables positioning of the patient with millimeter precision.

"This is a bold and impressive project and we are delighted that IPO Porto has selected Varian equipment and software to equip it," says Michael Sandhu, head of Varian's Oncology Systems business in Europe. "When clinical treatments start, this equipment will make a huge difference to cancer patients in the region, not only in additional treatment machines but also in the use of more efficient procedures."

IPO Porto is a public health institution of international renown in the treatment, research and teaching of cancer, often treating the most complex cancer cases in the north of the country. In 2008, almost 3,000 new cancer patients were treated at the institute.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radio
'/>"/>

SOURCE Varian Medical Systems, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Varian Medical Systems to Exhibit a Wide Selection of Flat Panel X-Ray Image Detectors and X-Ray Tubes at the CMEF Show in Chengdu, China
2. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
3. Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
4. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
5. Pivotal Registration Trial of OPAXIO Maintenance Therapy in First-Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients, Cell Therapeutics and the Gynecologic Oncology Group Discuss Potential for Early Interim Analysis
6. FDA Clears a Test for Ovarian Cancer
7. Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
8. Oasmia: FDA Grants Paclical(R) Orphan Drug Designation for Ovarian Cancer in the USA
9. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
10. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
11. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass